Largest positions
| Issuer | Class | Value | Share |
|---|---|---|---|
| State Str SPDR S&P 500 ETF T (put option)TR UNIT | TR UNIT | $4,480,620,000 | 20.7% |
| Revolution Medicines Inc.COM | COM | $2,537,793,075 | 11.7% |
| Electronic Arts Inc.COM | COM | $1,623,814,280 | 7.5% |
| Bridgebio Pharma Inc.COM | COM | $800,143,332 | 3.7% |
| Protagonist Therapeutics Inc.COM | COM | $778,248,897 | 3.6% |
| Exelixis Inc.COM | COM | $732,794,424 | 3.4% |
| Liquidia CorporationCOM NEW | COM NEW | $666,944,480 | 3.1% |
| Amazon Com Inc.COM | COM | $627,547,790 | 2.9% |
| Lantheus Hldgs Inc.COM | COM | $619,431,160 | 2.9% |
| Natera Inc.COM | COM | $602,175,451 | 2.8% |
| Unitedhealth Group Inc.COM | COM | $528,071,215 | 2.4% |
| Thermo Fisher Scientific Inc.COM | COM | $526,019,392 | 2.4% |
| Roivant Sciences LtdSHS | SHS | $506,395,510 | 2.3% |
| Aon PLCSHS CL A | SHS CL A | $458,581,990 | 2.1% |
| Boston Scientific Corp.COM | COM | $449,044,133 | 2.1% |
| Broadcom Inc.COM | COM | $435,092,450 | 2.0% |
| Microsoft Corp.COM | COM | $415,120,156 | 1.9% |
| Tango Therapeutics Inc.COM | COM | $383,779,020 | 1.8% |
| KKR & CO Inc.COM | COM | $377,977,574 | 1.7% |
| Synopsys Inc.COM | COM | $370,059,672 | 1.7% |
| Beam Therapeutics Inc.COM | COM | $351,313,111 | 1.6% |
| Crinetics Pharmaceuticals INCOM | COM | $336,372,047 | 1.6% |
| Grail Inc.COM | COM | $284,111,340 | 1.3% |
| WabtecCOM | COM | $241,158,009 | 1.1% |
| Immunovant Inc.COM | COM | $223,666,650 | 1.0% |
| Twist Bioscience Corp.COM | COM | $219,792,832 | 1.0% |
| Agios Pharmaceuticals Inc.COM | COM | $219,594,714 | 1.0% |
| AramarkCOM | COM | $206,304,094 | 1.0% |
| Baidu Inc.SPON ADR REP A | SPON ADR REP A | $137,580,588 | 0.6% |
| Novo-nordisk A SADR | ADR | $125,554,860 | 0.6% |
| Acadia Healthcare Company INCOM | COM | $124,640,224 | 0.6% |
| Brightspring Health Svcs Inc.COM | COM | $120,845,472 | 0.6% |
| Astrazeneca PLCORD | ORD | $108,841,880 | 0.5% |
| Johnson & JohnsonCOM | COM | $103,619,760 | 0.5% |
| iShares TR (put option)ISHARES SEMICDTR | ISHARES SEMICDTR | $83,298,800 | 0.4% |
| Strategy Inc.NOTE 12/0 | NOTE 12/0 | $75,366,666 | 0.3% |
| Parabilis Medicines Inc.COM | COM | $64,817,634 | 0.3% |
| Novartis AGSPONSORED ADR | SPONSORED ADR | $56,889,360 | 0.3% |
| Guardant Health Inc.COM | COM | $48,339,666 | 0.2% |
| Vnet Group Inc.NOTE 2.000%10/0 | NOTE 2.000%10/0 | $46,808,834 | 0.2% |
| Avalo Therapeutics Inc.COM NEW | COM NEW | $46,163,040 | 0.2% |
| Joyy Inc.ADS REPSTG COM A | ADS REPSTG COM A | $46,140,208 | 0.2% |
| Assembly Biosciences Inc.COM NEW | COM NEW | $44,094,133 | 0.2% |
| Enanta Pharmaceuticals Inc.COM | COM | $35,257,385 | 0.2% |
| Maze Therapeutics Inc.COM | COM | $33,057,170 | 0.2% |
| CG Oncology Inc. (call option)COM | COM | $28,420,000 | 0.1% |
| Merck & CO Inc.COM | COM | $25,571,500 | 0.1% |
| Warby Parker Inc.CL A COM | CL A COM | $25,121,520 | 0.1% |
| Perceptive Cap Solutions CorCL A ORD SHS | CL A ORD SHS | $24,480,000 | 0.1% |
| Kailera Therapeutics Inc.COMMON STOCK | COMMON STOCK | $24,233,000 | 0.1% |
State Str SPDR S&P 500 ETF T (put option)TR UNIT$4,480,620,000
- Class
- TR UNIT
- Share
- 20.7%
Revolution Medicines Inc.COM$2,537,793,075
- Class
- COM
- Share
- 11.7%
Electronic Arts Inc.COM$1,623,814,280
- Class
- COM
- Share
- 7.5%
Bridgebio Pharma Inc.COM$800,143,332
- Class
- COM
- Share
- 3.7%
Protagonist Therapeutics Inc.COM$778,248,897
- Class
- COM
- Share
- 3.6%
Exelixis Inc.COM$732,794,424
- Class
- COM
- Share
- 3.4%
Liquidia CorporationCOM NEW$666,944,480
- Class
- COM NEW
- Share
- 3.1%
Amazon Com Inc.COM$627,547,790
- Class
- COM
- Share
- 2.9%
Lantheus Hldgs Inc.COM$619,431,160
- Class
- COM
- Share
- 2.9%
Natera Inc.COM$602,175,451
- Class
- COM
- Share
- 2.8%
Unitedhealth Group Inc.COM$528,071,215
- Class
- COM
- Share
- 2.4%
Thermo Fisher Scientific Inc.COM$526,019,392
- Class
- COM
- Share
- 2.4%
Roivant Sciences LtdSHS$506,395,510
- Class
- SHS
- Share
- 2.3%
Aon PLCSHS CL A$458,581,990
- Class
- SHS CL A
- Share
- 2.1%
Boston Scientific Corp.COM$449,044,133
- Class
- COM
- Share
- 2.1%
Broadcom Inc.COM$435,092,450
- Class
- COM
- Share
- 2.0%
Microsoft Corp.COM$415,120,156
- Class
- COM
- Share
- 1.9%
Tango Therapeutics Inc.COM$383,779,020
- Class
- COM
- Share
- 1.8%
KKR & CO Inc.COM$377,977,574
- Class
- COM
- Share
- 1.7%
Synopsys Inc.COM$370,059,672
- Class
- COM
- Share
- 1.7%
Beam Therapeutics Inc.COM$351,313,111
- Class
- COM
- Share
- 1.6%
Crinetics Pharmaceuticals INCOM$336,372,047
- Class
- COM
- Share
- 1.6%
Grail Inc.COM$284,111,340
- Class
- COM
- Share
- 1.3%
WabtecCOM$241,158,009
- Class
- COM
- Share
- 1.1%
Immunovant Inc.COM$223,666,650
- Class
- COM
- Share
- 1.0%
Twist Bioscience Corp.COM$219,792,832
- Class
- COM
- Share
- 1.0%
Agios Pharmaceuticals Inc.COM$219,594,714
- Class
- COM
- Share
- 1.0%
AramarkCOM$206,304,094
- Class
- COM
- Share
- 1.0%
Baidu Inc.SPON ADR REP A$137,580,588
- Class
- SPON ADR REP A
- Share
- 0.6%
Novo-nordisk A SADR$125,554,860
- Class
- ADR
- Share
- 0.6%
Acadia Healthcare Company INCOM$124,640,224
- Class
- COM
- Share
- 0.6%
Brightspring Health Svcs Inc.COM$120,845,472
- Class
- COM
- Share
- 0.6%
Astrazeneca PLCORD$108,841,880
- Class
- ORD
- Share
- 0.5%
Johnson & JohnsonCOM$103,619,760
- Class
- COM
- Share
- 0.5%
iShares TR (put option)ISHARES SEMICDTR$83,298,800
- Class
- ISHARES SEMICDTR
- Share
- 0.4%
Strategy Inc.NOTE 12/0$75,366,666
- Class
- NOTE 12/0
- Share
- 0.3%
Parabilis Medicines Inc.COM$64,817,634
- Class
- COM
- Share
- 0.3%
Novartis AGSPONSORED ADR$56,889,360
- Class
- SPONSORED ADR
- Share
- 0.3%
Guardant Health Inc.COM$48,339,666
- Class
- COM
- Share
- 0.2%
Vnet Group Inc.NOTE 2.000%10/0$46,808,834
- Class
- NOTE 2.000%10/0
- Share
- 0.2%
Avalo Therapeutics Inc.COM NEW$46,163,040
- Class
- COM NEW
- Share
- 0.2%
Joyy Inc.ADS REPSTG COM A$46,140,208
- Class
- ADS REPSTG COM A
- Share
- 0.2%
Assembly Biosciences Inc.COM NEW$44,094,133
- Class
- COM NEW
- Share
- 0.2%
Enanta Pharmaceuticals Inc.COM$35,257,385
- Class
- COM
- Share
- 0.2%
Maze Therapeutics Inc.COM$33,057,170
- Class
- COM
- Share
- 0.2%
CG Oncology Inc. (call option)COM$28,420,000
- Class
- COM
- Share
- 0.1%
Merck & CO Inc.COM$25,571,500
- Class
- COM
- Share
- 0.1%
Warby Parker Inc.CL A COM$25,121,520
- Class
- CL A COM
- Share
- 0.1%
Perceptive Cap Solutions CorCL A ORD SHS$24,480,000
- Class
- CL A ORD SHS
- Share
- 0.1%
Kailera Therapeutics Inc.COMMON STOCK$24,233,000
- Class
- COMMON STOCK
- Share
- 0.1%
The share class is shown on a wider screen.
The 50 largest of 89 positions by value, with holdings of the same security combined. The 89 largest are in this firm's machine-readable record. Share counts and quarter-on-quarter changes for each position are on EDGAR. View the full information table on EDGAR
This filing
- Form
- 13F-HR
- CIK
- 909661
- File number
- 028-03896
- Options
- 1 call, 2 put
- In the 25 largest
- 89.3%
- Prior quarter
- $19,065,622,743 at 31 March 2026
- Positions opened
- 23
- Positions closed
- 107
Common questions
What are Farallon Capital Management’s 13F holdings worth?
$21,675,731,270 across 89 positions for the quarter ended 30 June 2026.
What is Farallon Capital Management’s largest 13F holding?
STATE STR SPDR S&P 500 ETF T (TR UNIT) was the largest position at $4,480,620,000, or 20.7% of reported 13F value, as of 30 June 2026.
How concentrated is Farallon Capital Management’s 13F portfolio?
The ten largest positions accounted for 62.1% of reported value and the twenty-five largest for 89.3%, across 89 positions as of 30 June 2026.
Does Form 13F show everything Farallon Capital Management manages?
No. Form 13F covers only long positions in exchange-traded securities over which the manager has investment discretion, valued at quarter end. It excludes cash, most bonds, private funds, and any assets the firm does not have discretion over, so it is neither the firm's total assets nor any individual client's portfolio.
How often does Farallon Capital Management file its 13F?
Every quarter. Managers file within 45 days of each quarter's end, so the figures are a snapshot that changes between filings. This page shows the quarter ended 30 June 2026.
Answered from this filing and the prior quarter's.